Jordi Costa I Colomer
Profesional
Research group
Professional network profiles
Last Publications
- Pastor-Vivero MD, Costa-Colomer J, Martín de Vicente C, Vicente-Santamaria S, Garcia Romero R, González Jiménez D and Luna Paredes C Advances in the treatment of cystic fibrosis: CFTR modulators. anales de pediatria . 102(5): 503857-503857.
- Costa-Colomer J, Garcia-Moyano M, Maiz L, Perez-Tarazona S, Ruiz de Valbuena M, Ceberio L, Correcher P, Julià-Palacios NA, Morales M, Pérez-Yagüe G, Villarrubia J and Pérez-Rojo R The impact of interstitial lung disease in patients with acid sphingomyelinase deficiency (ASMD) - A case series Respiratory Medicine Case Reports . 55: 102202-102202.
- Semenchuk J, Naito Y, Charman SC, Carr SB, Cheng SY, Marshall BC, Faro A, Elbert A, Gutierrez HH, Goss CH, Karadag B, Burgel PR, Colombo C, Salvatore M, Padoan R, Daneau G, Harutyunyan S, Kashirskaya N, Kirwan L, Middleton PG, Ruseckaite R, de Monestrol I, Naehrlich L, Mondejar-Lopez P, Jung A, van Rens J, Bakkeheim E, Orenti A, Zomer-van Ommen D, da Silva-Filho LVR, Fernandes FF, Zampoli M and Stephenson AL Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study. Journal of Cystic Fibrosis . 23(5): 815-822.
Projects
- Project name:
- PULMONASMD”: SCREENING OF ASMD DISEASE IN ADULT AND PEDIATRIC PATIENTS WITH ILD
- Leader
- Jordi Costa i Colomer
- Funding entities:
- RESPIRA - Fundación Española del Pulmón
- Code
- PCP00497
- Starting - finishing date:
- 2026 - 2027
